EP2763677 - NOVEL IMIDAZOLE QUINOLINE-BASED IMMUNE SYSTEM MODULATORS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 01.01.2021 Database last updated on 24.08.2024 | |
Former | The patent has been granted Status updated on 24.01.2020 | ||
Former | Grant of patent is intended Status updated on 17.01.2020 | ||
Former | Examination is in progress Status updated on 04.12.2019 | ||
Former | Grant of patent is intended Status updated on 22.07.2019 | ||
Former | Examination is in progress Status updated on 27.05.2019 | ||
Former | Grant of patent is intended Status updated on 22.01.2019 | ||
Former | Examination is in progress Status updated on 07.04.2017 | Most recent event Tooltip | 08.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 10.08.2022 [2022/32] | Applicant(s) | For all designated states Janus Biotherapeutics, Inc. 222 Third Street Suite 2240 Cambridge, MA 02142 / US | For all designated states Lipford, Grayson, B. 45 Grenville Road Watertown, MA 02472 / US | For all designated states Zepp, Charles, M. 940 North Road Hardwick, MA 01037 / US | [2020/09] |
Former [2014/33] | For all designated states Janus Biotherapeutics, Inc. 222 Third Street Suite 2240 Cambridge, MA 02142 / US | ||
For all designated states Lipford, Grayson, B. 45 Grenville Road Watertown, MA 02472 / US | |||
For all designated states Zepp, Charles, M. 940 North Road Hardwick, MA 01037 / US | Inventor(s) | 01 /
LIPFORD, Grayson, B. 45 Grenville Road Watertown, MA 02472 / US | 02 /
ZEPP, Charles, M. 940 North Road Hardwick, MA 01037 / US | [2014/33] | Representative(s) | HGF HGF Limited 1 City Walk Leeds LS11 9DX / GB | [N/P] |
Former [2020/09] | HGF Limited Saviour House 9 St. Saviourgate York YO1 8NQ / GB | ||
Former [2014/42] | Taylor, Kate Laura HGF Limited Saviour House 9 St Saviourgate York YO1 8NQ / GB | ||
Former [2014/33] | Lunt, Mark George Francis HGF Limited Fountain Precinct Balm Green Sheffield S1 2JA / GB | Application number, filing date | 12837804.9 | 03.10.2012 | [2020/09] | WO2012US58566 | Priority number, date | US201161543082P | 04.10.2011 Original published format: US 201161543082 P | [2014/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2013052550 | Date: | 11.04.2013 | Language: | EN | [2013/15] | Type: | A2 Application without search report | No.: | EP2763677 | Date: | 13.08.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 11.04.2013 takes the place of the publication of the European patent application. | [2014/33] | Type: | B1 Patent specification | No.: | EP2763677 | Date: | 26.02.2020 | Language: | EN | [2020/09] | Search report(s) | International search report - published on: | US | 15.05.2014 | (Supplementary) European search report - dispatched on: | EP | 17.04.2015 | Classification | IPC: | A61K31/535, C07D471/00, A01N43/42, A61K31/44 | [2014/33] | CPC: |
C07D471/04 (EP,US);
A61P1/04 (EP);
A61P1/16 (EP);
A61P17/00 (EP);
A61P17/06 (EP);
A61P19/02 (EP);
A61P21/00 (EP);
A61P21/04 (EP);
A61P25/00 (EP);
A61P29/00 (EP);
A61P3/10 (EP);
A61P37/06 (EP);
A61P5/00 (EP);
A61P7/04 (EP);
A61P7/06 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/33] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | NEUE IMMUNSYSTEMMODULATOREN AUF IMIDAZOLCHINOLIN-BASIS | [2014/33] | English: | NOVEL IMIDAZOLE QUINOLINE-BASED IMMUNE SYSTEM MODULATORS | [2014/33] | French: | NOUVEAUX MODULATEURS DU SYSTÈME IMMUNITAIRE À BASE D'IMIDAZOLE QUINOLINE | [2014/33] | Entry into regional phase | 30.04.2014 | National basic fee paid | 30.04.2014 | Search fee paid | 30.04.2014 | Designation fee(s) paid | 30.04.2014 | Examination fee paid | Examination procedure | 30.04.2014 | Examination requested [2014/33] | 10.11.2015 | Amendment by applicant (claims and/or description) | 10.04.2017 | Despatch of a communication from the examining division (Time limit: M04) | 25.07.2017 | Reply to a communication from the examining division | 24.08.2017 | Despatch of a communication from the examining division (Time limit: M04) | 21.12.2017 | Reply to a communication from the examining division | 26.04.2018 | Despatch of a communication from the examining division (Time limit: M02) | 28.06.2018 | Reply to a communication from the examining division | 23.01.2019 | Communication of intention to grant the patent | 23.05.2019 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 23.07.2019 | Communication of intention to grant the patent | 29.11.2019 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 29.11.2019 | Fee for grant paid | 29.11.2019 | Fee for publishing/printing paid | 16.01.2020 | Information about intention to grant a patent | 16.01.2020 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 10.04.2017 | Opposition(s) | 27.11.2020 | No opposition filed within time limit [2021/05] | Fees paid | Renewal fee | 27.10.2014 | Renewal fee patent year 03 | 27.10.2015 | Renewal fee patent year 04 | 27.10.2016 | Renewal fee patent year 05 | 27.10.2017 | Renewal fee patent year 06 | 29.10.2018 | Renewal fee patent year 07 | 28.10.2019 | Renewal fee patent year 08 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 03.10.2012 | AL | 26.02.2020 | AT | 26.02.2020 | CY | 26.02.2020 | CZ | 26.02.2020 | DK | 26.02.2020 | EE | 26.02.2020 | ES | 26.02.2020 | FI | 26.02.2020 | HR | 26.02.2020 | IT | 26.02.2020 | LT | 26.02.2020 | LV | 26.02.2020 | MC | 26.02.2020 | MK | 26.02.2020 | MT | 26.02.2020 | NL | 26.02.2020 | PL | 26.02.2020 | RO | 26.02.2020 | RS | 26.02.2020 | SE | 26.02.2020 | SI | 26.02.2020 | SK | 26.02.2020 | SM | 26.02.2020 | TR | 26.02.2020 | BG | 26.05.2020 | NO | 26.05.2020 | GR | 27.05.2020 | IS | 26.06.2020 | PT | 19.07.2020 | LU | 03.10.2020 | BE | 31.10.2020 | [2022/31] |
Former [2022/30] | HU | 03.10.2012 | |
AL | 26.02.2020 | ||
AT | 26.02.2020 | ||
CY | 26.02.2020 | ||
CZ | 26.02.2020 | ||
DK | 26.02.2020 | ||
EE | 26.02.2020 | ||
ES | 26.02.2020 | ||
FI | 26.02.2020 | ||
HR | 26.02.2020 | ||
IT | 26.02.2020 | ||
LT | 26.02.2020 | ||
LV | 26.02.2020 | ||
MC | 26.02.2020 | ||
MT | 26.02.2020 | ||
NL | 26.02.2020 | ||
PL | 26.02.2020 | ||
RO | 26.02.2020 | ||
RS | 26.02.2020 | ||
SE | 26.02.2020 | ||
SI | 26.02.2020 | ||
SK | 26.02.2020 | ||
SM | 26.02.2020 | ||
TR | 26.02.2020 | ||
BG | 26.05.2020 | ||
NO | 26.05.2020 | ||
GR | 27.05.2020 | ||
IS | 26.06.2020 | ||
PT | 19.07.2020 | ||
LU | 03.10.2020 | ||
BE | 31.10.2020 | ||
Former [2022/27] | HU | 03.10.2012 | |
AT | 26.02.2020 | ||
CY | 26.02.2020 | ||
CZ | 26.02.2020 | ||
DK | 26.02.2020 | ||
EE | 26.02.2020 | ||
ES | 26.02.2020 | ||
FI | 26.02.2020 | ||
HR | 26.02.2020 | ||
IT | 26.02.2020 | ||
LT | 26.02.2020 | ||
LV | 26.02.2020 | ||
MC | 26.02.2020 | ||
MT | 26.02.2020 | ||
NL | 26.02.2020 | ||
PL | 26.02.2020 | ||
RO | 26.02.2020 | ||
RS | 26.02.2020 | ||
SE | 26.02.2020 | ||
SI | 26.02.2020 | ||
SK | 26.02.2020 | ||
SM | 26.02.2020 | ||
TR | 26.02.2020 | ||
BG | 26.05.2020 | ||
NO | 26.05.2020 | ||
GR | 27.05.2020 | ||
IS | 26.06.2020 | ||
PT | 19.07.2020 | ||
LU | 03.10.2020 | ||
BE | 31.10.2020 | ||
Former [2022/26] | AT | 26.02.2020 | |
CZ | 26.02.2020 | ||
DK | 26.02.2020 | ||
EE | 26.02.2020 | ||
ES | 26.02.2020 | ||
FI | 26.02.2020 | ||
HR | 26.02.2020 | ||
IT | 26.02.2020 | ||
LT | 26.02.2020 | ||
LV | 26.02.2020 | ||
MC | 26.02.2020 | ||
NL | 26.02.2020 | ||
PL | 26.02.2020 | ||
RO | 26.02.2020 | ||
RS | 26.02.2020 | ||
SE | 26.02.2020 | ||
SI | 26.02.2020 | ||
SK | 26.02.2020 | ||
SM | 26.02.2020 | ||
TR | 26.02.2020 | ||
BG | 26.05.2020 | ||
NO | 26.05.2020 | ||
GR | 27.05.2020 | ||
IS | 26.06.2020 | ||
PT | 19.07.2020 | ||
LU | 03.10.2020 | ||
BE | 31.10.2020 | ||
Former [2021/36] | AT | 26.02.2020 | |
CZ | 26.02.2020 | ||
DK | 26.02.2020 | ||
EE | 26.02.2020 | ||
ES | 26.02.2020 | ||
FI | 26.02.2020 | ||
HR | 26.02.2020 | ||
IT | 26.02.2020 | ||
LT | 26.02.2020 | ||
LV | 26.02.2020 | ||
MC | 26.02.2020 | ||
NL | 26.02.2020 | ||
PL | 26.02.2020 | ||
RO | 26.02.2020 | ||
RS | 26.02.2020 | ||
SE | 26.02.2020 | ||
SI | 26.02.2020 | ||
SK | 26.02.2020 | ||
SM | 26.02.2020 | ||
BG | 26.05.2020 | ||
NO | 26.05.2020 | ||
GR | 27.05.2020 | ||
IS | 26.06.2020 | ||
PT | 19.07.2020 | ||
LU | 03.10.2020 | ||
BE | 31.10.2020 | ||
Former [2021/31] | AT | 26.02.2020 | |
CZ | 26.02.2020 | ||
DK | 26.02.2020 | ||
EE | 26.02.2020 | ||
ES | 26.02.2020 | ||
FI | 26.02.2020 | ||
HR | 26.02.2020 | ||
IT | 26.02.2020 | ||
LT | 26.02.2020 | ||
LV | 26.02.2020 | ||
MC | 26.02.2020 | ||
NL | 26.02.2020 | ||
PL | 26.02.2020 | ||
RO | 26.02.2020 | ||
RS | 26.02.2020 | ||
SE | 26.02.2020 | ||
SI | 26.02.2020 | ||
SK | 26.02.2020 | ||
SM | 26.02.2020 | ||
BG | 26.05.2020 | ||
NO | 26.05.2020 | ||
GR | 27.05.2020 | ||
IS | 26.06.2020 | ||
PT | 19.07.2020 | ||
LU | 03.10.2020 | ||
Former [2021/10] | AT | 26.02.2020 | |
CZ | 26.02.2020 | ||
DK | 26.02.2020 | ||
EE | 26.02.2020 | ||
ES | 26.02.2020 | ||
FI | 26.02.2020 | ||
HR | 26.02.2020 | ||
IT | 26.02.2020 | ||
LT | 26.02.2020 | ||
LV | 26.02.2020 | ||
NL | 26.02.2020 | ||
PL | 26.02.2020 | ||
RO | 26.02.2020 | ||
RS | 26.02.2020 | ||
SE | 26.02.2020 | ||
SI | 26.02.2020 | ||
SK | 26.02.2020 | ||
SM | 26.02.2020 | ||
BG | 26.05.2020 | ||
NO | 26.05.2020 | ||
GR | 27.05.2020 | ||
IS | 26.06.2020 | ||
PT | 19.07.2020 | ||
Former [2020/50] | CZ | 26.02.2020 | |
DK | 26.02.2020 | ||
EE | 26.02.2020 | ||
ES | 26.02.2020 | ||
FI | 26.02.2020 | ||
HR | 26.02.2020 | ||
LT | 26.02.2020 | ||
LV | 26.02.2020 | ||
NL | 26.02.2020 | ||
RO | 26.02.2020 | ||
RS | 26.02.2020 | ||
SE | 26.02.2020 | ||
SK | 26.02.2020 | ||
SM | 26.02.2020 | ||
BG | 26.05.2020 | ||
NO | 26.05.2020 | ||
GR | 27.05.2020 | ||
IS | 26.06.2020 | ||
PT | 19.07.2020 | ||
Former [2020/49] | CZ | 26.02.2020 | |
DK | 26.02.2020 | ||
ES | 26.02.2020 | ||
FI | 26.02.2020 | ||
HR | 26.02.2020 | ||
LT | 26.02.2020 | ||
LV | 26.02.2020 | ||
NL | 26.02.2020 | ||
RO | 26.02.2020 | ||
RS | 26.02.2020 | ||
SE | 26.02.2020 | ||
SK | 26.02.2020 | ||
SM | 26.02.2020 | ||
BG | 26.05.2020 | ||
NO | 26.05.2020 | ||
GR | 27.05.2020 | ||
IS | 26.06.2020 | ||
PT | 19.07.2020 | ||
Former [2020/48] | DK | 26.02.2020 | |
ES | 26.02.2020 | ||
FI | 26.02.2020 | ||
HR | 26.02.2020 | ||
LT | 26.02.2020 | ||
LV | 26.02.2020 | ||
NL | 26.02.2020 | ||
RO | 26.02.2020 | ||
RS | 26.02.2020 | ||
SE | 26.02.2020 | ||
SM | 26.02.2020 | ||
BG | 26.05.2020 | ||
NO | 26.05.2020 | ||
GR | 27.05.2020 | ||
IS | 26.06.2020 | ||
PT | 19.07.2020 | ||
Former [2020/47] | DK | 26.02.2020 | |
ES | 26.02.2020 | ||
FI | 26.02.2020 | ||
HR | 26.02.2020 | ||
LT | 26.02.2020 | ||
LV | 26.02.2020 | ||
NL | 26.02.2020 | ||
RS | 26.02.2020 | ||
SE | 26.02.2020 | ||
BG | 26.05.2020 | ||
NO | 26.05.2020 | ||
GR | 27.05.2020 | ||
IS | 26.06.2020 | ||
Former [2020/45] | FI | 26.02.2020 | |
HR | 26.02.2020 | ||
LV | 26.02.2020 | ||
NL | 26.02.2020 | ||
RS | 26.02.2020 | ||
SE | 26.02.2020 | ||
BG | 26.05.2020 | ||
NO | 26.05.2020 | ||
GR | 27.05.2020 | ||
IS | 26.06.2020 | ||
Former [2020/40] | FI | 26.02.2020 | |
HR | 26.02.2020 | ||
LV | 26.02.2020 | ||
RS | 26.02.2020 | ||
SE | 26.02.2020 | ||
BG | 26.05.2020 | ||
NO | 26.05.2020 | ||
GR | 27.05.2020 | ||
IS | 26.06.2020 | ||
Former [2020/39] | FI | 26.02.2020 | |
HR | 26.02.2020 | ||
LV | 26.02.2020 | ||
RS | 26.02.2020 | ||
SE | 26.02.2020 | ||
BG | 26.05.2020 | ||
NO | 26.05.2020 | ||
GR | 27.05.2020 | ||
Former [2020/38] | FI | 26.02.2020 | |
HR | 26.02.2020 | ||
LV | 26.02.2020 | ||
RS | 26.02.2020 | ||
SE | 26.02.2020 | ||
NO | 26.05.2020 | ||
GR | 27.05.2020 | ||
Former [2020/37] | FI | 26.02.2020 | |
HR | 26.02.2020 | ||
LV | 26.02.2020 | ||
RS | 26.02.2020 | ||
SE | 26.02.2020 | ||
NO | 26.05.2020 | ||
Former [2020/35] | FI | 26.02.2020 | |
NO | 26.05.2020 | Documents cited: | Search | [X]EP0145340 (RIKER LABORATORIES INC [US]) [X] 1,2,12 * page 47; compounds 153,154 *; | [XI]EP1104764 (HOKURIKU PHARMACEUTICAL [JP]) [X] 1,2,4,6-9,12-14 * paragraphs [0001] , [0009] * * examples 184-186 * * claim 1 * [I] 11,15; | [A]US2005004144 (CARSON DENNIS A [US], et al) [A] 1-15* claims 1,83 *; | [X]EP1972629 (MUTABILIS SA [FR]) [X] 1,2,10,12 * page 36, paragraph 216 * * end compound on the right side *; | [XI]US2010120741 (BORCHARDT ALLEN J [US], et al) [X] 1,2,12-14 * paragraph [0306] * * examples 158-163 * [I] 11,15; | [A]US2010158928 (STOERMER DORIS [US], et al) [A] 1-15 * paragraph [0233] * * claim 1 *; | [X] - CHEN, HAIQUAN ET AL, "Synthesis of derivatives of 1H-imidazo[4,5-c]quinoline", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (20070101), Database accession no. 2008:1103424, URL: STN, XP002737903 [X] 1,2,4,12 * abstract * * RN= 1160307-80-1; RN= 1160307-81-2; RN= 1160307-82-3 * | International search | [Y]US2007232622 (LIPFORD GRAYSON B [US], et al); | [Y]US2009069314 (KSHIRSAGAR TUSHAR A [US], et al); | [Y]US2010160314 (LIPFORD GRAYSON B [US], et al); | [Y]US2011136801 (ISOBE YOSHIAKI [JP], et al) |